95 related articles for article (PubMed ID: 5033669)
1. Studies on blood coagulation factor V. V. Changes of molecular weight accompanying activation of factor V by thrombin and the procoagulant protein of Russell's viper venom.
Kahn MJ; Hemker HC
Thromb Diath Haemorrh; 1972 Feb; 27(1):25-32. PubMed ID: 5033669
[No Abstract] [Full Text] [Related]
2. Observations on the Factor V activator present in Russell's viper venom and its action on Factor V.
Hanahan DJ; Rolfs MR; Day WC
Biochim Biophys Acta; 1972 Nov; 286(1):205-11. PubMed ID: 4676549
[No Abstract] [Full Text] [Related]
3. Separation from Russell's viper venom of one fraction reacting with factor X and another reacting with factor V.
Schiffman S; Theodor I; Rapaport SI
Biochemistry; 1969 Apr; 8(4):1397-405. PubMed ID: 5817155
[No Abstract] [Full Text] [Related]
4. Effects of antithrombin III and antivenom on procoagulant activity of Russell's viper venom in a whole blood model.
Clemens R; Lorenz R; Pukrittayakamee S; Punpoowang B; Vanijanonta S; Charoenlarp P
Southeast Asian J Trop Med Public Health; 1995 Mar; 26(1):143-8. PubMed ID: 8525402
[TBL] [Abstract][Full Text] [Related]
5. Practical applications of snake venom toxins in haemostasis.
Marsh N; Williams V
Toxicon; 2005 Jun; 45(8):1171-81. PubMed ID: 15922782
[TBL] [Abstract][Full Text] [Related]
6. Studies on pharmacological effects of Russell's viper and Saw-scaled viper venom and its neutralization by chicken egg yolk antibodies.
Meenatchisundaram S; Parameswari G; Michael A; Ramalingam S
Int Immunopharmacol; 2008 Aug; 8(8):1067-73. PubMed ID: 18550009
[TBL] [Abstract][Full Text] [Related]
7. The action of Russell's viper venom on factor V and the prothrombin-converting principle.
Prentice CR; Ratnoff OD
Br J Haematol; 1969 Mar; 16(3):291-302. PubMed ID: 5815894
[No Abstract] [Full Text] [Related]
8. Removal from bovine prothrombin of the substrate for Russell's viper venom.
Milstone JH; Oulianoff N
Thromb Diath Haemorrh; 1969 Apr; 21(2):203-16. PubMed ID: 5814014
[No Abstract] [Full Text] [Related]
9. Understanding Russell's viper venom factor V activator's substrate specificity by surface plasmon resonance and in-silico studies.
Yadav PK; Antonyraj CB; Basheer Ahamed SI; Srinivas S
PLoS One; 2017; 12(7):e0181216. PubMed ID: 28732041
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel pro-coagulant metalloprotease (RVBCMP) possessing alpha-fibrinogenase and tissue haemorrhagic activity from venom of Daboia russelli russelli (Russell's viper): evidence of distinct coagulant and haemorrhagic sites in RVBCMP.
Mukherjee AK
Toxicon; 2008 Apr; 51(5):923-33. PubMed ID: 18249434
[TBL] [Abstract][Full Text] [Related]
11. A change in Russell's viper venom (Stypven): modification of factor V assay to compensate.
Pool JG; Robinson AJ
J Lab Clin Med; 1971 Feb; 77(2):343-5. PubMed ID: 5540777
[No Abstract] [Full Text] [Related]
12. The purification and properties of activated factor X. Bovine factor X activated with Russell's viper venom.
Radcliffe RD; Barton PG
J Biol Chem; 1972 Dec; 247(23):7735-42. PubMed ID: 4636332
[No Abstract] [Full Text] [Related]
13. The action of thrombin on blood clotting factor V: conversion of factor V to a prothrombin-binding protein.
Esmon CT; Owen WG; Duiguid DL; Jackson CM
Biochim Biophys Acta; 1973 May; 310(1):289-94. PubMed ID: 4736336
[No Abstract] [Full Text] [Related]
14. Isolation of a novel inhibitor of kallikrein, plasmin and trypsin from the venom of Russell's viper (Vipera russelli).
Takahashi H; Iwanaga S; Suzuki T
FEBS Lett; 1972 Nov; 27(2):207-10. PubMed ID: 4541477
[No Abstract] [Full Text] [Related]
15. The determination of factor X in tissue homogenates. Evidence for the inactivation of Russell's viper venom by tissue homogenates in the presence of plasma.
Woolf IL; Kipnes RS; Babior BM
J Lab Clin Med; 1973 Jan; 81(1):77-84. PubMed ID: 4682190
[No Abstract] [Full Text] [Related]
16. Factor V.
Colman RW
Prog Hemost Thromb; 1976; 3():109-43. PubMed ID: 133374
[No Abstract] [Full Text] [Related]
17. Effect of intravenous injection of stypven or thrombin on coagulation and fibrinolysis of blood and lymph in dogs.
Leandoer L; Niléhn JE
Acta Chir Scand; 1969; 135(1):7-13. PubMed ID: 5805947
[No Abstract] [Full Text] [Related]
18. Human coagluation factor V purification and thrombin-catalyzed activation.
Dahlbäck B
J Clin Invest; 1980 Sep; 66(3):583-91. PubMed ID: 7400329
[TBL] [Abstract][Full Text] [Related]
19. [Procoagulant properties of beta/gamma-thrombin].
Semenova OA; Strukova SM
Vopr Med Khim; 1982; 28(4):137-40. PubMed ID: 6810543
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of human coagulation factor V.
Kane WH; Majerus PW
J Biol Chem; 1981 Jan; 256(2):1002-7. PubMed ID: 7451453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
